MODERN PRINCIPLES OF DIAGNOSTICS AND ANTIBACTERIAL THERAPY OF PROSTHETIC JOINT INFECTION (REVIEW)

Cover Page


Cite item

Full Text

Abstract

The hip and knee replacement was widely adopted in orthopedic surgery. It is high on the list on intervention volume, size of bleeds and to development of the general and local complications. Infectious complications are one of the basic and most expensive problems with significant socially losses after arthroplasty. Early diagnosis, selection of surgical tactics, accurate identification of the responsible microorganisms and choice of an effective antibiotic are important components of successful treatment of prosthetic joint infection. Main principles of diagnostics and rational antibacterial therapy of prosthetic infection are presented in the review.

About the authors

S. A. Bozhkova

ФГБУ «Российский научно-исследовательский институт травматологии и ортопедии им. Р.Р. Вредена» Минздравсоцразвития России

Author for correspondence.
Email: clinpharm-rniito@yandex.ru
к.м.н., заведующая отделением клинической фармакологии Россия

References

  1. Белобородов, В.Б. Актуальные вопросы антимикробной терапии хирургических инфекций / В.Б. Белобородов // Инфекции в хирургии. – 2003. – № 1. – С. 28–30.
  2. Божкова, С.А. Этиологическая структура и антибиотикорезистентность ведущих возбудителей парапротезной инфекции в стационаре травматолого-ортопедического профиля / С.А. Божкова, Т.М. Петрова, Н.Э. Мирзоев // Рациональная фармакотерапия и клиническая фармакология : сб. науч. матер. V Конгресса.– СПб., 2010. – С. 49–52.
  3. Пичхадзе, И.М. Лечение больных с гнойно-воспалительными осложнениями после эндопротезирования тазобедренного сустава / И.М. Пичхадзе [и др.] / Вестн. травматологии и ортопедии им. Н.Н. Приорова. – 2009. – № 3. – С.45–50.
  4. Практическое руководство по антиинфекционной химиотерапии / под ред. Л.С. Страчунского, Ю.Б. Белоусова, С.Н. Козлова. – Смоленск : МАКМАХ, 2007. – 464 с.
  5. Рак, А.В. Хирургические инфекции опорно-двигательного аппарата. Остеомиелиты / А.В. Рак // Хирургические инфекции : практ. руководство / под ред. И.А.Ерюхина, Б.Р. Гельфанда. С.А.Шляпникова. – М., 2006. – С. 635–678.
  6. Решедько, Г.К. Механизмы резистентности к аминогликозидам у нозокомиальных грамотрицательных бактерий в России: результаты многоцентрового исследования / Г.К. Решедько // Клин. микробиология и антимикробная химиотерапия. – 2001. – № 3. – С. 111–125.
  7. Сидоренко, С.В. Инфекции в интенсивной терапии / С.В. Сидоренко, С.В. Яковлев. – М. : Бионика, 2003. – 208 с.
  8. Сидоренко, С.В. Микробиологические аспекты хирургических инфекций. / С.В. Сидоренко // Инфекции в хирургии.– 2003. – № 1.– С. 22–27.
  9. Страчунский, Л.С. Сравнительная активность антибактериальных препаратов, входящих в лекарственные формы для местного применения в отношении Staphylococcus aureus: результаты российского многоцентрового исследования / Л.С. Страчунский [и др.] // Клин. микробиология и антимикробная химиотерапия. – 2002.– Т.4, № 2. – С. 157–163.
  10. Тец, В.В. Микроорганизмы и антибиотики. Инфекции кожи, мягких тканей, костей и суставов / В.В. Тец. – СПб. : КЛЕ-Т, 2006.– 128 с.
  11. Шагинян, И.А. Неферментирующие грамотрицательные бактерии в этиологии внутрибольничных инфекций: клинические, микробиологические и эпидемические особенности / И.А. Шагинян, М.Ю. Чернуха // Клин. микробиология и антимикробная химиотерапия. – 2005. – Т. 7, № 3. – С. 271–285.
  12. Al Arfaj, A.S. A prospective study of the incidence and characteristics of septic arthritis in a teaching hospital in Riyadh, Saudi Arabia / A.S. Al Arfaj // Clin. Rheumatol.– 2008– Vol.27. – P. 1403–1410.
  13. Arnold, S.R. Changing patterns of acute hematogenous osteomyelitis and septic arthritis: emergence of community–associated methicillin-resistant Staphylococcus aureus / S.R. Arnold [et al.] // J. Pediatr. Orthop. – 2006. – Vol.26. – P. 703–708.
  14. Atkins, B. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty / B. Atkins [et al.] // J. Clin. Microbiol. – 1998. – Vol. 36. – P. 2932–2939.
  15. Berbari, E. Risk factors for prosthetic joint infection: case-control study / E. Berbari [et al.] // Clin. Infect. Dis. – 1998. – Vol.27, N 5. – P. 1247–1254.
  16. Byren, I. One hundred and twelve infected arthroplasties treated with “DAIR” (debridement, antibiotics and implant retention): antibiotic duration and outcome / I. Byren [et al.] // J. Antimicrob. Chemother. – 2009. – Vol. 63, N 3. – P. 1264–1271.
  17. CDC. Staphylococcus aureus resistant to vancomycin. – United States, 2002. MMWR.– 2002.– N 51.– P. 565 – 567.
  18. CDC. Staphylococcus aureus resistant to vancomycin. – United States, 2002. MMWR.– 2002.– N 51.– P. 902–903.
  19. Dubost, J.J. No changes in the distribution of organisms responsible for septic arthritis over a 20 year period / J.J. Dubost [et al.] // Ann. Rheum. Dis. – 2002. – Vol.61, N 3. – P. 267–269.
  20. Eaton, T.J. Molecular screening of Enterococcus virulence determinants and potentional for genetic exchange between food and medical isolates / T.J. Eaton, M.J. Gasson // Appl. Environ. Microbiol. – 2001. – Vol.67, N 4. – P. 1628–1635.
  21. Fenollar, F. Analysis of 525 samples to determine the usefulness of PCR amplification and sequencing of the 16S rRNA gene for diagnosis of bone and joint infections / F. Fenollar [et al.] // J. Clin. Microbiol. – 2006. – Vol. 44. – P. 1018–1028.
  22. Fink, B. The value of synovial biopsy, joint aspiration and C–reactive protein in the diagnosis of late periprosthetic infection of total knee replacements / B. Fink [et al.] // J. Bone Joint Surg. – 2008. – Vol. 90-B. – P.874–878.
  23. Geipel, U. Pathogenic organisms in hip joint infections / U. Geipel // Int. J. Med. Sci. – 2009. – Vol. 6, N 5. – P. 234–240.
  24. Gold, H.S. Antimicrobial-drug resistance / H.S. Gold, R.C. Moellering // N. Engl. J. Med. – 1996. – N 335. – P. 1445–1453.
  25. Goldenberg, D.L. Septic arthritis / D.L. Goldenberg // Lancet. – 1998. – Vol. 351. – P. 197–202.
  26. Grammatico, L. Epidemiology of vertebral osteomyelitis (VO) in France: analysis of hospital-discharge data 2002–2008 / L. Grammatico [et al.] // Epidemiol. Infect. – 2008. – Vol. 136. – P. 653–660.
  27. Greig, J.M. Staphylococcus lugdunensis vertebral osteomyelitis / J.M. Greig, M.J. Wood // Clin. Microbiol. Infect. – 2003. – Vol. 9, N 11. – P. 1139–1141.
  28. Gristina, A. Infections from biomaterials and implants: a race for the surface / A. Gristina, P. Naylor, Q. Myrvik // Med. Prog. Technol. – 1988. – Vol.14. – P. 205–224.
  29. Hiramatsu, K. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility / K. Hiramatsu, H. Hanaki, T. Ino // J. Antimicrob. Chemother. – 1997. – Vol.40, N 1. – P.135–136.
  30. Howden, B.P. Reduced vancomycin susceptibility in staphylococcus aureus, including vancomycinintermediate and heterogeneous vancomycinintermediate strains: resistance mechanisms, laboratory detection, and clinical implications / B.P. Howden [et al.] // Clin. Microbiol. Rev. – 2010. – Vol. 3, N 1. – P. 99–139.
  31. Lee, K. Current state and future of joint replacements in the hip and knee / K. Lee, S.B. Goodman // Expert. Rev. Med. Devices. – 2008. – Vol. 5. – P. 383–393.
  32. Liu, C. Clinical practice guidelines by The Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus аureus infections in adults and children / C. Liu [et al.] // Clin. Infect. Dis. – 2011. – Vol. 52, N 1. – P.1–38.
  33. Marculescu, C.E. Polymicrobial prosthetic joint infections / C.E. Marculescu, J.R. Cantey // Clin. Orthop. – 2008. – N 466. – P. 1397–1404.
  34. Martínez-Pastor, J.C. Outcome of acute prosthetic joint infections due to gram–negative bacilli treated with open debridement and retention of the prosthesis / J.C. Martínez-Pastor [et al.] // Antimicrob. Agents Chemother. – 2009. – Vol. 53, N 11. – P.4772–4777.
  35. Moise-Broder, P. Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy / P. Moise-Broder [et al.] // Clin. Infect. Dis. – 2004. – Vol. 38, N 12. – P.1700–1705.
  36. Moran, E. Guiding empirical antibiotic therapy in orthopaedics: the microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention / E. Moran [et al.] // J. Infect. – 2007. – Vol. 55, N 1. – P. 1–7.
  37. Murdoch, D.R. Infection of orthopedic prostheses after Staphylococcus aureus bacteremia / D.R. Murdoch [et al.] // Clin. Infect. Dis. – 2001. – Vol. 32. – P. 647–649.
  38. Palestro, C.J. Combined labeled leukocyte and technetium 99m sulfur colloid bone marrow imaging for diagnosing musculoskeletal infection / C.J. Palestro [et al.] // Radiographics. – 2006. – Vol. 26. – P. 859–870.
  39. Pandey, R. Histological and microbiological findings in non-infected and infected revision arthroplasty tissues. The OSIRIS Collaborative Study Group. Oxford Skeletal Infection Research and Intervention Service / R. Pandey, A. Berendt, N. Athanasou // Arch. Orthop. Trauma Surg. – 2000. – Vol. 120. – P. 570–574.
  40. Phillips, C.B. Incidence rates of dislocation, pulmonary embolism and deep infection during the first six months after elective total hip replacement / C.B. Phillips [et al.] // J. Bone Joint Surg. – 2003. – Vol. 85-A, N 1. – P. 20–26.
  41. Raad, I. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm / I. Raad [et al.] // Antimicrobial Agents Chemotherapy. – 2007. – Vol. 51, N 5. – P. 1656–1660.
  42. Raad, I. Vancomycin-resistant Enterococcus faecium: catheter colonization, esp gene, and decreased susceptibility to antibiotics in biofilm / I. Raad [et al.] // Antimicrobial Agents Chemotherapy. – 2005. – Vol.49, N 12. – P. 5046–5050.
  43. Rao, N. Successful treatment of chronic bone and joint infections with oral linezolid / N. Rao, B.H. Ziran, R.A. Hall, E.R. Santa // Clin. Orthop. – 2004. – N 427. – P. 67–71.
  44. Rayner, C.R. Linezolid in the treatment of osteomyelitis: results of compassionate use experience / C.R. Rayner [et al.] // Infection. – 2004. – N 32. – P. 8–14.
  45. Rice, D. Daptomycin in bone and joint infections: a review of the literature / D. A. K. Rice, L. Mendez-Vigo // Arch. Orthop. Trauma. Surg. – 2009. – Vol. 129. – P. 1495–1504.
  46. Rybak, M. Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists / M. Rybak [et al.] // Am. J. Health-Syst. Pharm. – 2009. – Vol. 66. – P. 82–98.
  47. Schäfer, P. Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy / P. Schäfer [et al.] // Clin. Infect. Dis. – 2008. – Vol. 47. – P. 1403–1409.
  48. Skoulas, G. Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy / G. Skoulas, R.C.Jr. Moellering, G.M. Eliopoulos // Clin. Infect. Dis. – 2006. – Vol. 42, Suppl. 1. – S. 40–50.
  49. Trampuz, A. Prosthetic joint infections: update in diagnosis and treatment / A. Trampuz, W. Zimmerli // Swiss. Med. Wkly. – 2005. – Vol. 135. – P. 243–251.
  50. Trampuz, A. Sonication of removed hip and knee prostheses for diagnosis of infection / A. Trampuz [et al.] // N. Engl. J. Med. – 2007. – Vol. 357. – P. 654–663.
  51. Traunmüller, F. Soft tissue and bone penetration abilities of daptomycin in diabetic patients with bacterial foot infections / F. Traunmüller [et al.] // J. Antimicrob. Chemother. – 2010. – Vol. 65, N 6. – P. 1252–1257.
  52. U.K. Health Protection Agency, 2008. Surgical Site Infection – National aggregated data on Surgical Site Infections for hospitals that have participated in Surgical Site Infection Surveillance Scheme (SSISS) between October 1997 and December 2005. – http://www.hpa.org.uk/HPA/Topics/InfectiousDiseases/InfectionsAZ/120211553626/.
  53. Vallianou, N. Vertebral osteomyelitis and native valve endocarditis due to Staphylococcus simulans: a case report / N. Vallianou [et al.] // J. Med. Case Reports. – 2008. – N 2. – P. 183.
  54. Widmer, A.F. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations / A.F. Widmer, A. Gaechter, P.E. Ochsner, W. Zimmerli // Clin. Infect. Dis. – 1992. – Vol. 14, N 6. –P. 1251–1253.
  55. Wilson, M. Infection as a complication of total kneereplacement arthroplasty. Risk factors and treatment in sixty seven cases / M. Wilson, K. Kelley, T. Thornhill // J. Bone Joint Surg. – 1990. – Vol.72-A. – P. 878–883.
  56. Yin, L.Y. Comparative evaluation of tigecycline and vancomycin with and without rifampicin, in the treatment of methicillin resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model / L.Y. Yin [et al.] // J. Antimicrob. Chemother. – 2005. – Vol. 55. – P. 995–1002.
  57. Zimmerli, W. Infection and musculoskeletal conditions: prosthetic joint-associated infections / W. Zimmerli // Best. Pract. Res. Clin. Rheumatol. – 2006. – Vol. 20. – P.1045–1063.
  58. Zimmerli, W. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group / W. Zimmerli, A.F. Widmer, M. Blatter // JAMA. – 1998. – Vol. 279. – P. 1537–1541.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c)


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 82474 от 10.12.2021.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies